Ito Y - Search Results

1

Analysis of cytotoxic activity of the CD4+ T lymphocytes generated by local immunotherapy.

Katsumoto Y, Monden T, Takeda T, Haba A, Ito Y, Wakasugi E, Wakasugi T, Sekimoto M, Kobayashi T, Shiozaki H, Shimano T, Monden M. Katsumoto Y, et al. Among authors: ito y. Br J Cancer. 1996 Jan;73(1):110-6. doi: 10.1038/bjc.1996.20. Br J Cancer. 1996. PMID: 8554971 Free PMC article.

2

Role of urokinase-type plasminogen activator in local immunotherapy.

Takeda T, Ito Y, Wakasugi E, Kobayashi T, Monden M. Takeda T, et al. Among authors: ito y. Oncol Rep. 1998 Mar-Apr;5(2):329-33. Oncol Rep. 1998. PMID: 9468551

3

The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages.

Takeda T, Kobayashi T, Monden T, Katsumoto Y, Ito Y, Wakasugi E, Wakasugi T, Tomita N, Shimano T, Mori T. Takeda T, et al. Among authors: ito y. Biotherapy. 1993;7(1):47-54. doi: 10.1007/BF01878153. Biotherapy. 1993. PMID: 8068483 Clinical Trial.

4

Expression of p21 (WAF1/CIP1) protein in clinical thyroid tissues.

Ito Y, Kobayashi T, Takeda T, Komoike Y, Wakasugi E, Tamaki Y, Tsujimoto M, Matsuura N, Monden M. Ito Y, et al. Br J Cancer. 1996 Oct;74(8):1269-74. doi: 10.1038/bjc.1996.528. Br J Cancer. 1996. PMID: 8883416 Free PMC article.

5

Fas antigen expression in hepatocellular carcinoma tissues.

Ito Y, Takeda T, Umeshita K, Sakon M, Wakasa K, Matsuura N, Monden M. Ito Y, et al. Oncol Rep. 1998 Jan-Feb;5(1):41-4. Oncol Rep. 1998. PMID: 9458289

6

Both cell proliferation and apoptosis significantly predict shortened disease-free survival in hepatocellular carcinoma.

Ito Y, Matsuura N, Sakon M, Takeda T, Umeshita K, Nagano H, Nakamori S, Dono K, Tsujimoto M, Nakahara M, Nakao K, Monden M. Ito Y, et al. Br J Cancer. 1999 Oct;81(4):747-51. doi: 10.1038/sj.bjc.6690758. Br J Cancer. 1999. PMID: 10574266 Free PMC article.

7

The status of Fas and Fas ligand expression can predict recurrence of hepatocellular carcinoma.

Ito Y, Monden M, Takeda T, Eguchi H, Umeshita K, Nagano H, Nakamori S, Dono K, Sakon M, Nakamura M, Tsujimoto M, Nakahara M, Nakao K, Yokosaki Y, Matsuura N. Ito Y, et al. Br J Cancer. 2000 Mar;82(6):1211-7. doi: 10.1054/bjoc.1999.1065. Br J Cancer. 2000. PMID: 10735508 Free PMC article.

8

Immunohistochemical study of Cell Cycle Modulators in G(1)-S Transition in Clinical Breast Cancer Tissue.

Ito Y, Kobayashi T, Takeda T, Komoike Y, Wakasugi E, Tamaki Y, Umeshita K, Monden T, Monden M. Ito Y, et al. Breast Cancer. 1996 Jun 28;3(2):93-104. doi: 10.1007/BF02966969. Breast Cancer. 1996. PMID: 11091560

9

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.

Ito Y, Takeda T, Sakon M, Tsujimoto M, Higashiyama S, Noda K, Miyoshi E, Monden M, Matsuura N. Ito Y, et al. Br J Cancer. 2001 May 18;84(10):1377-83. doi: 10.1054/bjoc.2000.1580. Br J Cancer. 2001. PMID: 11355950 Free PMC article.

10

Expression of the retinoblastoma gene product in clinical thyroid tissues.

Ito Y, Kobayashi T, Takeda T, Wakasugi E, Tamaki Y, Umeshita K, Monden T, Monden M. Ito Y, et al. Oncol Rep. 1996 Jan;3(1):57-62. Oncol Rep. 1996. PMID: 21594315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,187 results

Search Page

Filters